LIFEGLIMMER GMBH
Desconocido
BIOINDUSTRY 4.0: RI services to promote deep digitalization of Industrial Biotechnology towards smart biomanufactur...
Industrial Biotechnology (IB) is a Key Enabling Technology for the circular bio-economy, industrial renewal and European manufacturing auton...
2022-12-15 - 2026-12-31 | Financiado
2022-12-15 - 2026-12-31 | Financiado
EPHOR: Exposome project for health and occupational research
LIFEGLIMMER GMBH
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Exposures at the workplace contribute to many non-communicable diseases (NCDs) with a similar magnitude as urban air pollution or obesity. G...
2019-12-06 - 2025-06-30 | Financiado
2019-12-06 - 2025-06-30 | Financiado
TranSYS: Translational SYStemics Personalised Medicine at the Interface of Translational Research and System...
LIFEGLIMMER GMBH
participó en un
H2020:
H2020-MSCA-ITN-2019
TranSYS will recruit 15 ESRs to highly skilled jobs in the new area of Systems Health developing tools and approaches to exploit large and c...
2019-08-19 - 2024-06-30 | Financiado
2019-08-19 - 2024-06-30 | Financiado
PERICO: Peroxisome Interactions and Communication
LIFEGLIMMER GMBH
participó en un
H2020:
H2020-MSCA-ITN-2018
PERICO fosters education of ESRs in a project to uncover how a central metabolic organelle, the peroxisome, participates in controlling cell...
2018-08-30 - 2023-03-31 | Financiado
2018-08-30 - 2023-03-31 | Financiado
IBISBA 1.0: Industrial Biotechnology Innovation and Synthetic Biology Accelerator
LIFEGLIMMER GMBH
participó en un
H2020:
H2020-INFRAIA-2016-2017
The overarching aim of IBISBA 1.0 is to support and accelerate the uptake of industrial biotechnology as a key enabling technology for advan...
2017-11-24 - 2022-05-31 | Financiado
2017-11-24 - 2022-05-31 | Financiado
HaemMetabolome: Deciphering the Metabolism of Haematological Cancers
LIFEGLIMMER GMBH
participó en un
H2020:
H2020-MSCA-ITN-2015
It has long been realised that metabolism is central to cellular development, proliferation and homeostasis. Collectively, aberrations in me...
2015-08-07 - 2019-09-30 | Financiado
2015-08-07 - 2019-09-30 | Financiado
EmPowerPutida: Exploiting native endowments by re factoring re programming and implementing novel control loops in...
LIFEGLIMMER GMBH
participó en un
H2020:
H2020-BIOTEC-2014-2015
We aim to engineer the lifestyle of Pseudomonas putida to generate a tailored, re-factored chassis with highly attractive new-to-nature prop...
2015-03-13 - 2019-04-30 | Financiado
2015-03-13 - 2019-04-30 | Financiado
Chromatin3D: Chromatin Dynamics in Development and Disease
LIFEGLIMMER GMBH
participó en un
H2020:
H2020-MSCA-ITN-2014
The cell nucleus is organized and compartmentalized into a highly ordered structure that contains DNA, RNA, chromosomal and histone proteins...
2014-12-12 - 2018-12-31 | Financiado
2014-12-12 - 2018-12-31 | Financiado
INFECT: Improving Outcome of Necrotizing Fasciitis Elucidation of Complex Host and Pathogen Signatures that...
LIFEGLIMMER GMBH
participó en un
FP7:
The overall goal with INFECT is to advance our understanding of the pathophysiological mechanisms, prognosis, and diagnosis of the multifact...
Financiado
Financiado
SPLASH: Sustainable PoLymers from Algae Sugars and Hydrocarbons
LIFEGLIMMER GMBH
participó en un
FP7:
The 4-year SPLASH project will develop a new biobased industrial platform using microalgae as a renewable raw material for the sustainable p...
Financiado
Financiado
SYSMEDIBD: Systems medicine of chronic inflammatory bowel disease
LIFEGLIMMER GMBH
participó en un
FP7:
Inflammatory bowel disease (IBD) is a major health problem with severe co-morbidities, requiring life-long treatment. Oscillating processes,...
Financiado
Financiado
PERFUME: Peroxisomes key to cell performance and health
LIFEGLIMMER GMBH
participó en un
FP7:
The PERFUME (PERoxisome Formation, Function, MEtabolism) program is an interdisciplinary and intersectoral ITN providing state-of-the-art re...
Financiado
Financiado
* No se disponen de datos de la empresa actual.